Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
April 11th, 2019
Pupillary responses (light reflex) were measured for assessment of adequate seizure induction by electroconvulsive therapy using an automated infrared pupillometer immediately after electrical stimulation. Constriction ratio was calculated and compared with seizure quality.
The efficacy of ECT, electroconvulsive therapy, has been evaluated based on electroencephalography and increases in BP or HR, however, an increasing number of patient have adapted to ECT and rates of cardiovascular disease are increasing. On the other hand, pupillary responses can reflect sympathetic nervous activity or the degree of brain damage. This proposed method might be particularly useful for patients who have been administered anti-hypertensive drugs during ECT.
Pupillary response measurement using an automated infrared pupillometer can be conducted in a simple, precise, and objective way and not be affected by anesthetic agents or anti-hypertensive drugs. Additionally, the white light used for measuring light reflexes is not overly bright and harmful for patients. Begin by cleaning the right and left forehead and the area behind the ears with an alcohol cotton swab.
Next, attach electroencephalogram or EEG monitors at four symmetrical points. Clean bilateral temples with normal saline and then attach adhesive electrical stimulation pads to the bilateral temples to prevent interference in the stimulation due to hair. Then, attach the electrocardiogram or ECG monitors at the base of the heart and cardiac apex and monitor heart rate.
Next, prepare a tourniquet and belt it at the left thigh. Lastly, attach two electromyogram sensors to the left anterior tibial muscle with a distance of five centimeters to measure generalized seizure time in the lower leg. After anesthetizing the patient, begin the electroconvulsive therapy or ECT procedure by using an ECT instrument set at an initial electrical stimulus dose percentage at half the value of the patient's age.
Then, immediately after electrical stimulation, hold the automated infrared pupillometer over one of the patient's eyes. After the patient's eyes are opened by an examiner, press the device button and measure maximum resting pupil size or minimum pupil size after stimulation. Next, perform controlled ventilation using a face mask with 100%oxygen until the patient begins breathing spontaneously.
Finally, using EEG, measure ictal regularity, seizure time, and greater post-ictal suppression. Results indicate that pupillary diameter was increased after electrical stimulation, however, significant differences in constriction by the light reflex were caused immediately after electrical stimulation reflecting differences in seizure efficacy induced by ECT. For this study, automated infrared pupillometer is essential.
Measurements should be conducted immediately after electrical stimulation because pupillary reactions recover rapidly. For adequate seizure evaluation, pupillary reaction might be included in the future. Pupillary reaction might be one of the evaluations for degree of epilepsy or non-induced seizure.
Hemodynamics are dynamically changed immediately after electrical stimulation, therefore, the anesthesiologist should not excessively focus on evaluating pupillary response but ensure there is consistent monitoring of the patient's vital signs.
View the full transcript and gain access to thousands of scientific videos
Overview
This study investigates pupillary responses as a measure of seizure induction quality during electroconvulsive therapy (ECT). Using an automated infrared pupillometer, the constriction ratio was calculated and analyzed in relation to seizure quality.
Key Study Components
Area of Science
- Neuroscience
- Electrophysiology
- Clinical Psychology
Background
- Electroconvulsive therapy (ECT) is often evaluated through electroencephalography and cardiovascular responses.
- Pupillary responses can indicate sympathetic nervous activity and brain damage.
- Patients on anti-hypertensive drugs may benefit from this method.
- The measurement technique is objective and minimally invasive.
Purpose of Study
- To assess the effectiveness of ECT using pupillary responses.
- To provide a reliable method for evaluating seizure quality.
- To explore the impact of medications on pupillary reflexes during ECT.
Methods Used
- Automated infrared pupillometry for measuring pupillary responses.
- Comparison of constriction ratios post-electrical stimulation.
- Assessment of seizure quality in relation to pupillary data.
- Controlled environment to minimize external influences.
Main Results
- Pupillary responses correlated with the quality of seizures induced by ECT.
- The method proved effective regardless of anesthetic agents.
- Patients on anti-hypertensive drugs showed reliable pupillary reflexes.
- Results suggest a new avenue for evaluating ECT efficacy.
Conclusions
- Pupillary response measurement is a promising tool for assessing ECT.
- This method may enhance patient safety and treatment evaluation.
- Further research is needed to validate findings across diverse patient populations.
Frequently Asked Questions
Executive Industry Relevance
Objective measurement of pupillary response following electroconvulsive therapy (ECT) offers a novel, quantitative biomarker for assessing effective seizure induction in neuropsychiatric research. This approach addresses the need for reliable, drug-independent physiological readouts, especially in patient populations with cardiovascular comorbidities or on antihypertensive medications. Integrating automated pupillometry into early discovery and translational workflows enhances predictive confidence and supports risk-adjusted portfolio decisions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables objective interrogation of sympathetic nervous system activation as a functional biomarker.
- Supports mechanistic de-risking by isolating physiological responses unaffected by anesthetic or cardiovascular agents.
- Facilitates functional target validation for neuropsychiatric intervention strategies.
Screening & Assay Development
- Provides standardized, reproducible measurement of pupillary diameter and constriction ratios.
- Delivers quantitative outputs suitable for assay development and cross-study comparison.
- Enables reliable evaluation of seizure induction efficacy across diverse patient cohorts.
Translational & Preclinical Research
- Aligns physiological readouts with translational biomarker strategies for CNS disorders.
- Supports continuity from discovery-stage mechanistic studies to preclinical validation of seizure models.
- Reduces ambiguity in efficacy assessment for neuroactive compound screening.
Pipeline & Workflow Integration
Pupillary response measurement integrates into the ECT workflow as a quantitative, immediate post-stimulation readout, bridging early discovery, assay development, and translational research phases.
- Discovery Biology: Enables hypothesis testing on sympathetic activation and seizure efficacy independent of confounding drug effects.
- Screening: Provides reproducible, quantitative metrics for evaluating intervention impact on seizure induction.
- Analytics: Supports statistical comparison of constriction ratios and seizure quality across experimental arms.
- Translational Research: Facilitates alignment of physiological biomarkers with preclinical and clinical endpoints in CNS portfolios.
- Enterprise Reuse: Establishes a scalable, objective measurement platform for ongoing neuropsychiatric research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in seizure induction assessment and reduces mechanistic ambiguity.
- Operational Value: Delivers standardized, rapid, and reproducible physiological measurements across studies.
- Strategic Value: Improves go/no-go decision-making and capital allocation by providing robust efficacy biomarkers.
- Portfolio Impact: Enables risk-adjusted prioritization of neuropsychiatric assets based on objective physiological endpoints.
Implementation Considerations
- Requires expertise in neurophysiology and automated pupillometry instrumentation.
- Demands integration with EEG and cardiovascular monitoring infrastructure for comprehensive assessment.
- Necessitates cross-team standardization of measurement timing and data interpretation.
- Adaptation may be needed for different patient populations or CNS disease models.
- Measurements must be performed immediately post-stimulation due to rapid pupillary recovery.
